期刊文献+

尖锐湿疣患者外周血及经体外诱生的HPV16抗原特异性CD8^+细胞毒性T细胞检测 被引量:4

Quantification of peripheral blood HPV16 antigen-specific CD8^+ cytotoxic T cells in patients with condyloma acuminatum
原文传递
导出
摘要 目的研究尖锐湿疣患者外周血HPV16抗原特异性CD8^+细胞毒性T细胞(CTL)表型变化及正常人T细胞对病毒抗原肽体外刺激的细胞免疫应答反应在尖锐湿疣发病机制中的作用。方法采用免疫荧光标染重组MHCⅠ类分子-多肽五聚体技术,流式细胞仪定量检测10例尖锐湿疣患者外周血HPV16E7_(11-20)(HLA-A*0201/YMLDLQPETF)抗原特异性CTL(Pent^+CD8^+)、活化CTL(Pent^+CD8^+CD69^+)及记忆性CTL(Pent^+D8^+CD45RO^+)数量。同时,用HPV16E7_(11-20)合成多肽、重组人白介素7、白介素2体外刺激13例正常人外周血单一核细胞产生抗原特异性CTL,并对其进行表型分析,以无关肽HBVcore_(18-27)作为阴性对照。结果尖锐湿疣患者外周血CD8^+T细胞中HPV16抗原特异性CTL、活化CTL及记忆性CTL百分数分别为0.76%±0.43%.0.36%±0.20%及0.33%±0.15%,对照组分别为0.24%±0.07%,0.17%±0.05%及0.15%±0.06%。两组比较,P值分别<0.01,<0.05及<0.01。病毒多肽体外刺激T细胞7d后,抗原特异性CTL、活化CTL及记忆性CTL百分数分别为0.75%±0.16%,0.35%±0.15%及0.33%±0.18%,均比非刺激组的0.24%±0.06%,0.16%±0.03%及0.13%±0.04%明显增多,P值均<0.01。结论HPV感染诱导CD8^+T细胞克隆性增殖,产生抗原特异性CD8^+CTL,高效、特异性直接杀伤病毒感染的靶细胞,在抗病毒T细胞免疫应答过程中发挥作用。 Objective To study the roles of phenotype switch of HPV16 antigen-specific CD8^+ cytotoxic T cells ( CTLs ) in peripheral blood as well as the cellular immune response of human T lymphocytes to viral peptides in the pathogenesis of condyloma acuminatum. Methods HPV16E711-22 ( HLA-A*0201/YMLDLQPETT ) antigen-specific CTLs were stained with fluorescent-labeled recombinant MHC class Ⅰ -peptide pentamer complex, and co-stained with CD69 ( activated CTL ) and CD45RO ( memory CTL ) surface markers, in peripheral blood fi'om 10 patients with condyloma acuminatum and 15 normal controls. The CTLs were quantitated by flow cytometric analysis. Meanwhile, peripheral blood mononuclear cells of 13 healthy donors were incubated for 7 days with HPV16E711-20 peptide, recombinant human interleukin 7 and interleukin 2 to yield antigen-specific CD8^+ CTLs and their other surface markers. An irrelevant peptide, HBVcore18-27 ( FLPSDFFPSV ), was used as an isotype control. Results The percentages of peripheral blood HPV16E7 antigen-specific CD8^+CTLs, activated CTLs and memory CTLs of total CD8^+ T cells were increased significantly in patients with condyloma acuminatum ( 0.76% ±0.43 %, 0.36%±0.20%, and 0.33%±0.15%, respectively) than those in normal controls (0.24%±0.07%, 0.17%±0.05% and 0.15% ±0.06%, respectively ) (P 〈 0.01, P 〈 0.05, and P 〈 0.01, respectively ). For T cells in vitro stimulated with viral peptide for 7 days, the percentages of peptide-specific CD8+ CTLs, activated CTLs and memory CTLs were significantly higher ( 0.75% ±0.16%, 0.35% ±0.15% and 0.33% ±0.18%, respectively ) in comparison with those in non-stimulated group ( 0.24% ±0.06%, 0.16% ±0.03% and 0.13%± 0.04%, respectively ) ( P 〈 0.001, P 〈 0.01 and P 〈 0.01, respectively ). Conclusions These results, in vivo and in vitro, demonstrate that the proliferation of CD8^+ T cell clones induced by HPV infection could generate antigen-specific CD8^+ CTLs, causing a highly efficient and specific killing of viral-infected target cells directly, which may play an important role in antiviral T cell-mediated immune response.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2006年第5期260-262,共3页 Chinese Journal of Dermatology
关键词 尖锐湿疣 乳头状瘤病毒 T淋巴细胞 细胞毒性 Condylomata acuminata Papillomavirus, human T-lymphocytes, cytotoxic
  • 相关文献

参考文献8

  • 1Walboomers JM,Jacobs MV,Manos MM,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol,1999,189:12-19.
  • 2Nilges K,Hohn H,Pilch H,et al.Human papillomavirus type 16 E7 peptide-directed CD8^+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.J Virol,2003,77:5464-5474.
  • 3Scholten KB,Schreurs MW,Ruizendaal J J,et al.Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer.Clin Immunol,2005,114:119-129.
  • 4Altman JD,Moss PA,Goulder P J,et al.Phenotypic analysis of antigen-specific T lymphocytes.Science,1996,274:94-96.
  • 5Komatsu H,Sierro S,V Cuero A,et al.Population analysis of antiviral T cell responses using MHC class Ⅰ-peptide tetramers.Clin Exp Immunol,2003,134:9-12.
  • 6蒋明军,王书崎,龚向东,余艳华,陈强,高省,尹跃平,韩国柱,孙建方.尖锐湿疣皮损中人乳头瘤病毒基因分型研究[J].中华皮肤科杂志,2005,38(5):262-264. 被引量:39
  • 7唐旭,赵玉铭,董小平,何春涤,王雅坤,陈洪铎.尖锐湿疣患者外周血中HPVDNA的检测[J].中华皮肤科杂志,2003,36(5):258-260. 被引量:13
  • 8徐云升,郝飞,宋志强,钟白玉,郝进,叶庆佾.HPV16E7抗原的HLA-A2限制性细胞毒性T淋巴细胞表位的筛选与鉴定[J].中华皮肤科杂志,2004,37(5):283-284. 被引量:6

二级参考文献18

  • 1Pao CC, Lin SS, Lin CY, et al. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol, 1991, 95:540-546.
  • 2Tseng CJ, Lin CY, Wang RL, et al. Possible transplacental transmission of human papillomaviruses. Am J Obstet Gynecol, 1992, 166(1Pt 1 ):35-40.
  • 3Snijders PJ, Steenbergen RD, Meijer CJ, et al. Role of human papillomaviruses in cancer of the respiratory and upper digestive tract.Clin Dermatol, 1997, 15:415-425.
  • 4Karas Z, Poreba E. HPV sequences in blood of patients with condyloma acuminata. J Invest Dermatol, 1998, 110:843-844.
  • 5Tseng CJ, Pao CC, Lin JD, et al. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol,1999, 17:1391-1396.
  • 6Koutsky L. Epidemiology of genital human papillomavirus infection.Am J Med, 1997, 102: 3-8.
  • 7zur Hausen H. Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol, 1996, 122: 3-13.
  • 8No authors listed. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep, 1997, 46: 1-55.
  • 9Leonard CL, Zhu WY, Kinsey WH, et al. Trichilemmol/Lomas are not associated with human papillomavirus DNA. J Cutan Pathol, 1990,18: 193-197.
  • 10Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol, 2000, 38: 357-361.

共引文献54

同被引文献59

  • 1王沂芹,柏健鹰,傅晓岚,张静波,王惠明,赵婷婷,徐文岳,吴玉章.慢性乙型肝炎患者HBV特异性CTLs的KIR表达研究[J].免疫学杂志,2006,22(2):172-174. 被引量:8
  • 2张蓓,付晓岚,王靖雪,韩俊峰,吴玉章.乙型肝炎患者HBcAg18-27表位特异性细胞毒性T细胞的研究[J].免疫学杂志,2007,23(3):319-322. 被引量:19
  • 3Ahmed AM,Madkan V,Tyring SK.Human papillomaviruses and genital disease.Dermatol Clin,2006,24:157-165.
  • 4Kim TY,Myoung HI,Kim JH,et al.Both E7 and CpGoligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16(E6/E7) immortalized tumor cells:involvement of CD4+ and CD8+ T cell in protection.Cancer Res,2002,62:7234-7240.
  • 5E1 Sherif AM,Seth R,Tighe PJ,et al.Quantitative analysis of IL10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical ptecanoer.J Pathol,2001,195:179-185.
  • 6DeVoti JA,Steinberg BM,Rosenthal DW,et al.Failure of gamma interferon but ant interleukin-10 expression in response to human papillomavims type 11 E6 protein in respiratory papillomatosis.Clin Diagn Lab Immunol,2004,11:538-547.
  • 7Vukmanovic-Stejic M,Vyas B,Gorak-Stolinska P,et al.Human Tc1 and Tc2/TcO CD8 T-cell clones display distinct cell surface and functional phenotypes.Blood,2000,95:231-240.
  • 8Dcog Y,Yang D,Chen X,et al.Tc1/Tc2 imbalance in the peripheral blood of patients with recurrent genital herpes.J Huazhong Univ Sci Technol Med Sci,2006,26:145-147.
  • 9Derby E,Reddy V,Kopp W,et al.Three-color flow cytometric ssay for the study of the mechanisms of cell-mediated cytotoxicity.Immunol Lett,2001,78:35-39.
  • 10Bais AG,Beckmann I,Lindemaas J,et al.A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN Ⅲ lesions.J Clin Pathol,2005,58:1096-1100.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部